Agenus – The Right Combination Agenus discovers, manufactures and develops immuno-oncology products. The company’s I-O portfolio is comprised of checkpoint antibodies, cell therapies, vaccines, and adjuvants, representing a combination of synergistic agents to deliver curative patient outcomes. Enter #ctad2019 – Biogen sample size 3285 patients at 348 sites in 20Continue Reading